Cartesian Therapeutics (RNAC) Interest & Investment Income (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Interest & Investment Income of $1.0 million for Q1 2026, down 49.08% year-over-year from $2.0 million in Q1 2025, and down 19.09% quarter-over-quarter from $1.3 million in Q4 2025.
Cartesian Therapeutics (RNAC) Interest & Investment Income (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Interest & Investment Income data on file, last reported at $1.0 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $1.0 million, down 49.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 million (down 32.14% YoY), and the FY2025 annual result was $6.6 million, down 10.93% from the prior year.
- Interest & Investment Income retreated to $1.0 million in Q1 2026 per RNAC's latest filing, from $1.3 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $2.6 million in Q3 2024 and troughed at $15000.0 in Q1 2022.
- A 5-year average of $1.3 million and a median of $1.3 million in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2026: Interest & Investment Income soared 12577.78% in 2022, then sank 49.08% in 2026.
- A 5-year view of Interest & Investment Income shows it stood at $1.1 million in 2022, then declined by 17.62% to $940000.0 in 2023, then soared by 161.06% to $2.5 million in 2024, then tumbled by 48.33% to $1.3 million in 2025, then decreased by 19.09% to $1.0 million in 2026.
- Business Quant data shows RNAC's Interest & Investment Income at $1.0 million in Q1 2026, $1.3 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | 2.02 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 940,000.00 |
| Sep 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | 1.39 Mn |
| Mar 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 710,000.00 |
| Jun 30, 2022 | 207,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 12,000.00 |